The Excretion of Human Urinary Kallikrein Quantity and Activity in Normal and Low Renin Subgroups of Essential Hypertension
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 5 (3) , 329-337
- https://doi.org/10.3109/10641968309069492
Abstract
In both low and normal renin essential hypertensive groups, urinary excretion of kallikrein quantity by direct radioimmunoassay and activity by kininogenase assay were significantly lower than those in normal subjects. In comparing between normal and low renin groups, no difference was found in kallikrein quantity, while kallikrein activity tended to be lower in the low renin group than in the normal renin group. A significant positive correlation was observed between kallikrein quantity and activity in the normal subjects, the normal renin group and the low renin group. However, the slope of the regression line in the low renin group was significantly more moderate than that in the normal renin group, and tended to be more moderate than that in normal subjects. The addition of kallikrein inhibitors (aprotinin and gabexate mesilate) resulted in a significant suppression of enzymatic activity but not of enzyme quantity. These findings suggest that suppression of the renal kallikrein system in both groups of essential hypertension was confirmed by the decreased excretion of kallikrein both as enzyme quantity and activity, and that in the mechanism of the suppression of urinary kallikrein activity in the low renin group, the renal kallikrein inhibitors may play some role.Keywords
This publication has 15 references indexed in Scilit:
- Hemodynamic and natriuretic responses to intravenous infusion of dopamine in patients with essential hypertension.Japanese Circulation Journal, 1982
- Inactivation of urinary kallikrein by alpha1-antitrypsinJournal of Molecular Medicine, 1981
- Progressive Inhibition of Human Glandular (Urinary) Kallikrein by Human Serum and Identification of the Progressive Antikallikrein as α1-Antitrypsin (α1-Protease Inhibitor)Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1981
- The Radioimmunoassay of Human Urinary Kallikrein and Comparisons with Kallikrein Activity Measurements*Journal of Clinical Endocrinology & Metabolism, 1980
- Plasma Bradykinin Levels and Urinary Kallikrein Excretion in Normal Renin Essential Hypertension*Journal of Clinical Endocrinology & Metabolism, 1979
- Body Fluid Balance and Fractional Excretions of Sodium, Inorganic Phosphorus, Potassium and Free Water in Low Renin Essential Hypertension : VIII CONFERENCE ON THE PATHOGENESIS OF HYPERTENSIONJapanese Circulation Journal, 1979
- Vasodilators, Intrarenal Distribution of Blood Flow, and Renal Function in Isolated Perfused Canine KidneysExperimental Biology and Medicine, 1976
- A Kallikrein-Specific Inhibitor in Rat Kidney TubulesHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1976
- Urinary kallikrein excretion and sodium metabolism in hypertensive patients.The Tohoku Journal of Experimental Medicine, 1975
- Urinary Kallikrein Excretion in Normal ManCirculation Research, 1974